Article

Holden shortlisted for Eureka

Brien Holden, BAppSc, PhD, DSc, chief executive officer of the Brien Holden Vision Institute, has been shortlisted for a Eureka Prize, one of Australia?s top science awards.

Sydney, Australia-Brien Holden, BAppSc, PhD, DSc, chief executive officer of the Brien Holden Vision Institute, has been shortlisted for a Eureka Prize, one of Australia’s top science awards.

The Commonwealth Scientific and Industrial Research Organization’s Eureka Prize for Leadership in Science is awarded annually to an Australian who has had an outstanding role and impact in science. The prizes were established in 1990 to reward excellence in the fields of research and innovation, science leadership, school science, and science journalism and communication. Dr. Holden is one of three candidates shortlisted for the award; the winner will be announced Sept. 6.

Dr. Holden has helped establish and guide four major research organizations at the University of New South Wales, attracting researchers from around the world to collaborate on efforts to tackle the challenges facing optometry. He has also helped establish a series of humanitarian and education organizations, all working toward the goal of “vision excellence for all people.”

“Australia is blessed with many gifted science leaders who integrate their science talents with the people-skills necessary to make a sustainable difference,” Dr. Holden said. “To be shortlisted in the final three for one of Australia’s most high profile scientific awards is very humbling.”

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
© 2025 MJH Life Sciences

All rights reserved.